Cannabis-Focused Finance Company Altmore Capital Files For Nasdaq IPO

Specialty finance company Altmore BDC, Inc., also known as Altmore Capital, is looking to go public on the Nasdaq Capital Market. The firm announced today the launch of its initial public offering of 6.67 million common shares.

The firm is targeting the share price between US$14.50 and US$15.50 per share, which puts target proceeds from the offering at US$103.3 million on the high end of the range.

The shares are expected to trade on the Nasdaq big board under the symbol “ABDC”. The underwriters also have a 30-day over-allotment option to purchase additional 1.0 million shares.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

The proceeds from the offering are intended for investments in senior secured loans and general working capital purposes.

The finance firm services loans primarily to cannabis operators in the United States, including cultivators, processors, manufacturers, distributors, and retailers.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Is Agnico Eagle Seabridge Gold’s Mystery Lender?

This Gold Giant Is Building 1.5 Million More Ounces a Year | Agnico Eagle Q3 Earnings

This Gold Giant Was a Mess. Now It’s Back! | Barrick Mining Q3 2026 Earnings

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Oncology Firm TransCode Therapeutics Looks To Raise US$25 Million In IPO

Oncology company TransCode Therapeutics, Inc. is set to begin publicly trading its equityon the Nasdaq...

Friday, July 9, 2021, 09:53:00 AM

SpaceX Faces Iran Target Designation Ahead of Its Landmark IPO

Iran has formally designated Elon Musk’s SpaceX and Starlink facilities across the Middle East as...

Thursday, June 11, 2026, 10:16:53 AM

Viral Diseases Tester Virax Biolabs Prices Upsized US$6.75 Million IPO

Biopharmaceutical company Virax Biolabs Group Limited recently increased its initial public offering size as it...

Wednesday, June 22, 2022, 02:14:00 PM

Biotech Firm IN8bio Eyes US$40 Million IPO

Clinical-stage biopharmaceutical company IN8bio, Inc. (Nasdaq: INAB) began trading on the Nasdaq Global Market today...

Friday, July 30, 2021, 11:56:00 AM

SPAC Chavant Capital Acquisition Seeks To Raise US$80 Million In IPO

Special purpose acquisition company Chavant Capital Acquisition Corp. went public on Nasdaq Capital Market today....

Tuesday, July 20, 2021, 11:38:00 AM